Key result
Continuous lumbar plexus block with 0.125% ropivacaine resulted in similar 24-hour tramadol consumption compared to 0.2% ropivacaine, but reduced total ropivacaine use.
Why the study?
Lower concentrations of ropivacaine in continuous lumbar plexus block have not been studied adequately for postoperative pain relief following total hip arthroplasty.
Does 0.125% ropivacaine compared to 0.2% ropivacaine provide equivalent postoperative analgesia in patients undergoing total hip arthroplasty?
RCT (n=50)
Does 0.125% ropivacaine compared to 0.2% ropivacaine provide equivalent postoperative analgesia in patients undergoing total hip arthroplasty?
0.125% ropivacaine provides equivalent postoperative analgesia to 0.2% ropivacaine in continuous lumbar plexus block after total hip arthroplasty, with significantly lower local anesthetic consumption.
Answers are grounded in this paper and cite their sources.
Lower ropivacaine concentrations in continuous LPB may aid post-THA analgesia; leaves open optimal dosing pending larger trials.
Background: Lower concentrations of ropivacaine in continuous lumbar plexus block (LPB) have not been studied adequately. Thus, we designed this prospective, randomized, comparative study to evaluate the two different concentrations of ropivacaine (0.125% and 0.2%) in continuous LPB for postoperative pain relief following total hip arthroplasty (THA). Materials and Methods: Fifty patients undergoing THA under standardized subarachnoid block have been randomly allocated to receive a continuous infusion of either 0.125% (Group 1) or 0.2% (Group 2) of ropivacaine in LPB done under the guidance of peripheral nerve stimulator. The primary outcome was consumption of tramadol during the first 24 h and the secondary outcomes were quality of sensory and motor blockade and consumption of ropivacaine. Results: The total amount of tramadol did not differ significantly ( P = 0.442) between the two groups. Furthermore, the duration of sensory and motor blockade did not differ significantly between the two groups. However, the average consumption of ropivacaine was significantly lower in Group 1 when compared to Group 2 (238.80 mg vs. 380.64 mg, P = 0.0001). Conclusion: Administration of 0.125% of ropivacaine can be a better alternative as it would decrease the total amount of the local anesthetic in continuous LPB.
No takes yet. Share an insight, caveat, or question.
Murugesan et al. (2021) conducted an RCT in Total hip arthroplasty (n=50). Ropivacaine in continuous lumbar plexus block vs. 0.2% ropivacaine was evaluated on Consumption of tramadol during the first 24 h (p=0.442). Continuous lumbar plexus block with 0.125% ropivacaine resulted in similar 24-hour tramadol consumption compared to 0.2% ropivacaine, but reduced total ropivacaine use.
Synapse has enriched 10 related papers. Consider them for comparative context: